Rockwell Medical Inc (RMTI)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$7.990.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · RMTI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -71.7% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 9.6% |
Growth built into the price is above our model estimate.
The price assumes 81.3 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name has been missing across recent quarters and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 23 industry peers · Company calendar date is not available
RMTI — earnings miss
Dated 2026-08-13
and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Why it matters: The company received a notice of delisting. Compliance is crucial for continued listing.
Worry ifThe company confirms it follows Nasdaq listing rules.
Less concerning ifThe company does not meet Nasdaq listing rules. This risks delisting.
Why it matters: A shift in revenue growth could signal a change in the company's market position. Investors will want to see if the growth rate improves or continues to decline.
Watch forRevenue growth is speeding up again. This shows stronger demand.
Also watch forRevenue growth is slowing down. This shows ongoing market problems.
Why it matters: If this margin is reached, it shows better operations and pricing changes.
Supportive ifGross margin for Q2 2026 reaches or exceeds 18%.
Worry ifGross margin for Q2 2026 remains below 17%.
Why it matters: Positive cash flow is key for Rockwell Medical's financial health. It shows the company can sustain operations.
Supportive ifOperating cash flow becomes positive in 2026-Q2 or Q3.
Worry ifOperating cash flow remains negative in 2026-Q2 or Q3.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$217 on $10,000 · ±2.2% | How much price usually moves either way. |
| Bad day | $695 loss on $10,000 · 7.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,117 loss on $10,000 · 71.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: A larger decline in sales would signal ongoing customer issues and hurt growth prospects.
Worry ifQ2 2026 net sales decline more than 8% compared to Q2 2025.
Less concerning ifQ2 2026 net sales stabilize or grow year over year.
Why it matters: The earnings report will show how the company is doing. It can affect investor trust and stock value.
Watch forAnnouncement of the next earnings date with positive guidance or results.
Also watch forThe next earnings date is announced. Negative guidance or bad results may follow.
Why it matters: Meeting or exceeding this sales figure shows continued growth and demand for products. It confirms the company's growth strategy is working.
Supportive ifQ3 net sales reported at $17.8 million or higher.
Worry ifQ3 net sales fall below $17.8 million.
Why it matters: Positive cash flow shows better financial health and efficiency. It proves the company can keep running.
Supportive ifOperating cash flow reported as positive in Q3.
Worry ifOperating cash flow remains negative in Q3.
Why it matters: Better adjusted EBITDA shows improved performance. It helps the company reach its profit goals.
Supportive ifAdjusted EBITDA was close to $1 million in Q3.
Worry ifAdjusted EBITDA was still negative in Q3.
Why it matters: Staying compliant keeps the company on Nasdaq. It builds trust with investors and keeps market access.
Supportive ifCompany maintains a minimum closing bid price of $1.00 per share.
Worry ifThe company does not meet Nasdaq listing rules.
Why it matters: Keeping this margin range shows good cost control and pricing. It helps the company make more money.
Supportive ifGross margin reported at 18% or higher.
Worry ifGross margin drops below 18%.